When we launched I-STAT in the 1990s, level III neonatal intensive care units where our best customers for this reason. Our point of care analyzer used less than 100 microliters of blood versus over 300 microliters for traditional analyzers. This allowed for many fewer blood transfusions for the smallest babies since we drew less blood from them to run the assay. People often look at point of care analyzers for the backup convenience, quick turnaround time, or low cost. But small sample size, especially with those of diagnostic accuracy and precision, can be an additional and valuable benefit.